Geron Corporation ( GERN) - Key Metrics
GERN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.09 | -$0.02 | -$0.02 | -$0.02 |
| 2026Q1 | $0.08 | -$0.01 | -$0.09 | -$0.09 |
| 2025Q4 | $0.07 | -$0.05 | -$0.03 | -$0.03 |
| 2025Q3 | $0.07 | -$0.03 | -$0.02 | -$0.02 |
| 2025Q2 | $0.07 | -$0.02 | -$0.04 | -$0.04 |
GERN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -16 |
| 2026Q1 | 0% | -68.98 |
| 2025Q4 | 0% | -7.07 |
| 2025Q3 | 0% | -12.41 |
| 2025Q2 | 0% | -14.33 |
GERN
Price: $1.47
52 week price:
Earnings Per Share: -0.11 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 535483
Ebitda: -6.9 millionMarket Capitalization: 949.5 million